TTY Biopharm Co Ltd (4105) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.097x

Based on the latest financial reports, TTY Biopharm Co Ltd (4105) has a cash flow conversion efficiency ratio of 0.097x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$778.89 Million ≈ $24.54 Million USD) by net assets (NT$8.05 Billion ≈ $253.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

TTY Biopharm Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how TTY Biopharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 4105 total liabilities for a breakdown of total debt and financial obligations.

TTY Biopharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of TTY Biopharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sichuan Meifeng Chemical Industry Co Ltd SHE:000731	0.019x
Beijing Quanshi World Online Net SHE:002995	-0.109x
Vital Farms Inc NASDAQ:VITL	0.016x
Queen's Road Capital Investment Ltd. TO:QRC	0.001x
Anhui Wantong Technology Co Ltd SHE:002331	-0.056x
Opthea Ltd AU:OPT	0.460x
Audax Renovables S.A. MC:ADX	0.225x
DXN HOLDINGS BHD. KLSE:5318	0.041x

Annual Cash Flow Conversion Efficiency for TTY Biopharm Co Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of TTY Biopharm Co Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see market value of TTY Biopharm Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$8.05 Billion ≈ $253.66 Million	NT$1.76 Billion ≈ $55.51 Million	0.219x	+21.80%
2024-12-31	NT$7.51 Billion ≈ $236.64 Million	NT$1.35 Billion ≈ $42.51 Million	0.180x	+7.70%
2023-12-31	NT$6.51 Billion ≈ $204.98 Million	NT$1.09 Billion ≈ $34.19 Million	0.167x	-15.86%
2022-12-31	NT$6.23 Billion ≈ $196.38 Million	NT$1.24 Billion ≈ $38.93 Million	0.198x	-8.99%
2021-12-31	NT$5.77 Billion ≈ $181.70 Million	NT$1.26 Billion ≈ $39.58 Million	0.218x	+151.55%
2020-12-31	NT$6.08 Billion ≈ $191.49 Million	NT$526.35 Million ≈ $16.58 Million	0.087x	-55.84%
2019-12-31	NT$6.17 Billion ≈ $194.36 Million	NT$1.21 Billion ≈ $38.12 Million	0.196x	+16.74%
2018-12-31	NT$6.39 Billion ≈ $201.37 Million	NT$1.07 Billion ≈ $33.83 Million	0.168x	+3.03%
2017-12-31	NT$6.11 Billion ≈ $192.55 Million	NT$996.52 Million ≈ $31.40 Million	0.163x	--

About TTY Biopharm Co Ltd

TWO:4105 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$581.27 Million

NT$18.45 Billion TWD

Market Cap Rank

#11784 Global

#400 in Taiwan

Share Price

NT$74.20

Change (1 day)

+0.41%

52-Week Range

NT$72.10 - NT$86.30

All Time High

NT$97.91